Skip to main content

Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus nasal carriage in the West of Iran: a population-based cross-sectional study

Abstract

Background

Several reports designate the recent increase in community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) nasal carriage. Because of the scanty information regarding the nasal carriage sate of MRSA in the west of Iran, the purpose of the present study was to determine the frequency of CA-MRSA in Sanandaj city.

Methods

Swabs collected from anterior nares of 600 volunteers were analyzed for the presence of S. aureus. The isolates were further investigated for methicillin resistance by using the cefoxitin disk diffusion test, followed by PCR-amplification of the mecA gene. SCCmec types and the presence of the Panton-Valentine Leukocidin (pvl) encoding genes were determined through PCR. Finally, the antimicrobial susceptibility of the isolates was determined by the agar diffusion method.

Results

Nasal screening identified 181 S. aureus, of which 55 isolates were MRSA. SCCmec types IV and V were detected in MRSA at frequencies of 80 and 20%, respectively. The overall frequency of pvl genes among the MRSA isolates was 14.54%. MRSA isolates were highly susceptible (98.18%) to mupirocin, gentamicin, and fusidic acid.

Conclusions

The high prevalence of CA-MRSA carriage in the population could pose a serious public health concern for the region. Additionally, advent of drug-resistant pvl-positive strains demands continuous surveillance on the colonization state of CA-MRSA in order to prevent dissemination of the bacterium in the community.

Peer Review reports

Background

Staphylococcus aureus is one of the major human infectious agents, causing mild to life-threatening manifestations. Anterior nares is the most consistent ecological niche for S. aureus in humans [1]. Almost 50% of the healthy individuals harbor the bacterium in a persistent or intermittent status, asymptomatically [2]. It is documented that the endogenous source of S. aureus is responsible for almost 80% of staphylococcal infections in carriers [3]. In addition to pervasive increasing in S. aureus reservoirs, the advent of community-acquired methicillin-resistant S. aureus (CA-MRSA), which is generally multi or extensively drug-resistant, has complicated the therapeutic trials in recent years [4, 5]. Acquisition of mecA leads to encoding a low affinity penicillin-binding protein (PBP2a). Insertion of the mobile genetic elements carrying mecA in the bacterial chromosome nominates staphylococcal cassette chromosome mec (SCCmec) elements, among which types IV and V are carried by CA-MRSA [6, 7]. Further, distribution of diverse antimicrobial resistant genes within the community via resident strains is the other aspect of hazard imposed by CA-MRSA [8]. It is reported that traditional Hospital-acquired MRSA (HA-MRSA) are replaced by CA-MRSA [9]. Likewise, pvl-harboring CA-MRSA clones may involve in necrotizing pulmonary and skin infections through the expression of Panton-Valentine Leukocidin (PVL) toxin [10].

Despite the studies carried out on CA-MRSA carriage in various part of the world [11,12,13,14], and among healthy children [15, 16], medical and non-medical students [8], and outpatients [17, 18] in Iran, the prevalence of CA-MRSA in the community setting in the west of Iran is totally unknown. Therefore, this study was conducted to evaluate the nasal colonization state of MRSA on healthy individuals in Sanandaj city, west of Iran. Moreover, SCCmec types, presence of pvl, and antibiotic resistance profile of the isolates were further analyzed.

Methods

Samples and data collection

The frequency of S. aureus nasal carriage (SANC) and MRSA was investigated in a cross-sectional study from February 2017 to July 2018 among 600 randomly chosen inhabitants in Sanandaj city based on the non-probability haphazard sampling type. Any sign of clinical illness, hospitalization, and use of antibiotics during the 12 preceding months were excluded from the survey. The participants included 278 female and 322 male. The study was approved by the Ethics Committee of Sanandaj Medical University. An informed consent signed by all the participants or their legal guardians was obtained prior to enrollment. Details of the sampling population are depicted in Table 1.

Table 1 Age group and sex characteristics, and distribution of SANC and MRSA

S. aureus isolation

Sterile swabs moisture with sterile normal saline (SNS) was used for streaking both anterior nares of each participant. The swabs embedded in SNS were transferred to the microbiology laboratory within maximum two hours and streaked onto Columbia agar (CA, Merck, Germany) with 6% defibrinated sheep blood. An individual presumptive colony of S. aureus (round and convex with an approximate of 1–4 mm in diameter) from each plate was subcultured on blood agar (BA, Merck, Germany). Phenotypic characterization of the S. aureus isolates were performed based on Gram staining and the biochemical reactions including catalase, coagulase, and DNase positive bacteria, in addition to yellow appearance on mannitol salt agar (MSA, Merck, Germany).

DNA extraction and molecular analysis

Genomic DNA of the S. aureus isolates were extracted using gram positive bacterial DNA extraction kit (CinnaGen, Iran). The DNA of the isolates were subjected to a species-specific polymerase chain reaction (PCR) based on the nuc gene partial amplification [19]. Initial determination of MRSA was performed using cefoxitin disk (Patanteb, Iran) diffusion test [20], which was followed by mecA gene amplification [21]. SCCmec types (I-V) of MRSA isolates were discriminated in a multiplex PCR reaction as described by Ghaznavi-Rad et al. [22]. Finally, the presence of pvl gene was analyzed as proposed by Lina et al. [23]. Reference strain of S. aureus ATCC 49775 was applied as pvl positive control. Positive controls for SCCmec PCR were as followed: NCTC10442 (SCCmec I), NCTC N315 (SCCmec II), NCTC 85/2082 (SCCmec III), HDE288 (SCCmec IV), and JCSC3624 (SCCmec V).

Antimicrobial susceptibility testing

Agar disk diffusion method was exploited to assess the antimicrobial susceptibility pattern of isolated S. aureus strains [20]. The used antibiotic disks (Patanteb, Iran) included rifampin (5 μg), tetracyclin (30 μg), chloramphenicol (30 μg), fusidic acid (10 μg), trimethoprim-sulphamethoxazole (1.25/23.75 μg), clindamycin (2 μg), gentamicin (10 μg), erythromycin (15 μg), penicillin (10 U), vancomycin (30 μg), mupirocin (200 μg), and ciprofloxacin (5 μg). S. aureus ATCC 25923 was used for quality control point.

Statistical analysis

Demographic characteristics (gender and age-group variables) and risk factors of the studied population were primarily analyzed by bivariate model. P values ≤0.05 indicated statistically significant correlations at the 95.0% confidence level. Next, multiple logistic regression model was applied. In order to elevate the value of regression model, every given variable with a P value ≤0.05 was entered in the final multiple logistic model. The goodness of fit regarding multiple logistic regression model was evaluated by Hosmer and Lemeshow test. The results were expressed as P value and adjusted odds ratio (Adjusted OR) with a 95% confidence interval (CI 95%). Median ages expressed as mean ± SEM.

Results

In the present research, 181 (30.16%) colonized S. aureus isolates were detected, among which 68 (11.33%) and 113 (18.83%) strains were isolated from female and male subjects, respectively. The overall prevalence of MRSA in this study was 55 out of 181 S. aureus isolates, identified phenotypically and then confirmed in a mecA-based PCR assay. The most affected age-group among females and males were > 60–70 and > 10–20 years-old groups, respectively. Thirteen (2.16%) and 42 (7%) female and male candidates were detected as MRSA nasal carriers, respectively (Table 1).

The individuals with highest carriage rate of MRSA in both genders were in > 10–20 age group. The prevalence of MRSA in men was rather higher than that of women (Table 2). The median age of women and men enrollers were 36.27 ± 1.06 and 36.08 ± 1.09 years, respectively. The risk of MRSA (Adjusted OR: 3.86; 95% CI: 1.70–8.76) infection was significant with gender (Table 3). Meanwhile, significance association was observed between MRSA frequency with age (Adjusted OR: 0.92; 95% CI: 0.78–1.10) (Table 3). Besides, in bivariate logistic regression analysis, a significant association was revealed between the frequency of MRSA with some independent risk factors including skin and soft tissue infection in the last 12 months (Crude OR = 46.57, 95% CI: 2.03–1068.89), occupation (Crude OR = 1.32, 95% CI: 1.24–3.52), and the presence of household members who have a profession in hospital care (Crude OR = 13.07, 95% CI: 2.44–70.11) (Table 2). All of the above mentioned risk factors remained associated in the multiple logistic regression analysis, including skin and soft tissue infection in the last 12 months (Adjusted OR = 4.70, 95% CI: 1.22–18.18), occupation (Adjusted OR = 0.22, 95% CI: 0.09–0.51), and the presence of household members who have a profession in hospital care (Adjusted OR = 5.24, 95% CI: 1.86–14.76) (Table 3). No statistical relationship was identified between the other risk factors depicted in Table 2 and MRSA state. The P-value, crude odds ratio and confidence interval (CI) of the risk factors are accessible in Table 2.

Table 2 Bivariate analysis of demographic information and risk factors for MRSA
Table 3 Multiple logistic regression analysis of demographic information and risk factors associated with MRSA

A total of 44 (80%) MRSA isolates carried SCCmec type IV, among which eight isolates harbored pvl gene. The frequency of pvl and SCCmec type IV subtypes are represented in Table 4. In addition, SCCmec type V was detected in 11 (20%) MRSA isolates and only one of them harbored pvl gene. Other types of SCCmec including types I, II, and III were not detected in any isolates.

Table 4 Frequency of SCCmec type IV subtypes among MRSA isolates

The antibiotic resistance pattern of S. aureus including MRSA is presented in Table 5. Drug-resistance (resistance to at least 2 classes of antibiotics) was observed in 132 (72.92%) and 47 (87.27%) total S. aureus and MRSA isolates, respectively. Resistance to penicillin allocated the highest rate of resistance, following by clindamycin, erythromycin, and ciprofloxacin among the total and MRSA isolates. All MRSA isolates were susceptible to fusidic acid, gentamicin, and mupirocin, except one isolate. Besides, high rates of susceptibility were observed against the three above antibiotics in total isolated S. aureus.

Table 5 Antibiotic resistance profile of S. aureus isolated from nasal carriers in Sanandaj city

Discussion

Emergence and distribution of CA-MRSA clones is a universal public health issue. High frequency of colonized S. aureus detected in the present survey is a matter of concern as nasal carriers are at risk of acquiring endogenous Staphylococcal infections [8]. Relatively poor personal hygiene such as facial, hand, and nostril cleaning habit is a probable reason of the high rate of SANC in the region [24]. Although a reverse association has been stated between SANC and age [14], higher prevalence of SANC among elderly women in this study is ambiguous. This may be related to hormonal disposition [13]. As an evidence, consumption of hormonal contraceptives is identified as a risk factor for SANC [25]. On one hand, female sex hormones direct an immunomodulating effect which may modify the host innate and adaptive responses against infections. This is particularly about estrogen through the exertion of anti-inflammatory and pro-inflammatory effects at different physiological levels [26, 27]. On the other hand, the dynamics of SANC is indirectly affected by the existence of sex steroid receptors in the anterior nares, in addition to the microenvironment of nasal cavity which is influenced by sex hormones [24, 28]. The peak competition of respiratory pathogens to colonize in the anterior nares is in the first years of life, by which interfering of the bacteria confers their elimination or establishment [1]. Higher prevalence of SANC state is consistently documented in male gender [8, 13, 14]. Despite this, some observations have documented no differences regarding the SANC state in both genders [29]. Empirically experience of the authors denotes the less habit of hand washing among young boys. Although the impact of gender on SANC frequency is not completely known so far, enhanced attitude of female sex toward health issues, particularly personal hygiene, may influence the bacterial colonization rate [8].

The reported incidences of SANC in different studies vary, depending on the sampling sites and methods, and the methodology applied [12]. Lower frequency of SANC among apparently healthy individuals have been reported from Spain (19.1%) [12], Norway (27%) [30], Kashmir-India (27.92%) [31], and Germany (21.9%) [13], while the higher prevalence of SANC (40.4%) has been documented in Ukraine [32]. It is not out of mind that the prevalence rate of S. aureus in this study in under-estimated as other sites of body residing S. aureus (skin, vagina, pharynges) did not examined. In addition, enrichment processes did not employed for rising S. aureus isolation.

High level of CA-MRSA in this study poses a risk for not only carriers but also patients and susceptible individuals. The previous history of skin and soft tissue infections is independently associated with MRSA rate. Current studies have also confirmed MRSA colonization with surgical site infections or chronic furunculosis [33, 34]. Despite this, because of some controversial conflicts regarding association of MRSA colonization with several non-infectious skin diseases [35,36,37], the burden of CA-MRSA state in skin and soft tissue infections in the studied district is needed to investigate in details in upcoming studies. Despite the success in preventing recurrent skin infections following nasal decolonization with mupirocin [33], it has been failed in the cases of non-infectious skin diseases [38]. In other studies undertaken in Iran, the carriage state of MRSA among special groups including healthcare workers [39], children [16], students [8], and hospitalized individuals [40] were 5.3, 1.3, 13.14, and 36.8%, respectively. The nasal colonization rate of MRSA was reported 4.5% in a community based study carried out in Arak, central Iran [41]. The carriage rate of MRSA in Spain (0.4%) [12], Bolivia (0.5%) and Peru (0%) [11], Brazil (0.9%) [14], Germany (1.29%) [13], India (1.83%) [31], and Ukraine (3.7%) [32] were lower than the 9.16% detected in our study. Higher incidence of MRSA nasal carriage (16.6%) has been reported by Goud et al. [42], while Scerri et al. [43] and Onanuga et al. [44] has stated approximately close rate of MRSA nasal colonization from Malta (8.8%) and Niger delta (9%). Regular close contact with an active case or carrier, traffic to healthcare centers, poor sanitation or economic circumstances, preceding antibiotic prescription, and overcrowding are the plausible reasons to explain the differences of CA-MRSA prevalence in various regions [45, 46]. There is concordance between the results of the present work and Schaumburg et al. regarding peek colonization rate of the bacterium among teenagers [47]. The higher proportion of MRSA carriage state in male rather than female volunteers in this study complies with the results that presented elsewhere [8, 13, 30, 32]. Indeed, this is coincide with the observations reported from Arak, central Iran [48] and the USA [49].

The frequent harboring of SCCmec type IV among the MRSA isolates underscored their community-acquired origin. Similarly, predominate SCCmec type among CA-MRSA in other studies carried out in Iran [8, 41] and overseas [11, 12, 14] was type IV. IVa subtype had the most frequency in Urmia, the northwest of Iran, with the association of none detectable IVb and IVc subtypes [8]. Lozano et al. revealed IVc subtype as the dominant subtype of SCCmec type IV [12]. This emphasizes even the subtle genetic variations of CA-MRSA isolated in different areas.

Because of the PVL-positive CA-MRSA menace to cause soft tissue and skin infections in menage and close-contact social groups, it is assumed as a serious public health threat. The frequency of pvl gene among the CA-MRSA isolates in the present study was 14.54% (8 out of 55 isolates), which is higher than findings in the central [41] and the northwest of Iran [8]. While Fard-Mousavi et al. reported 20.8% prevalence for pvl [48]. PVL-negative CA-MRSA clones were reported from Spain [12], Bolivia [11], and Botucatu, Brazil [14]. In contrast, approximately high prevalence of pvl-harboring CA-MRSA isolates were detected from Ukraine (58%) [32]. Despite the prevailing distribution of pvl in CA-MRSA clones in Western countries rather than Eastern countries [50], mountainous subtropical climate condition of Sanandaj city may influence the higher prevalence of pvl in this city comparing to the mentioned European countries except Ukraine [51]. Meanwhile, due to the phage origin of pvl genes and their transmissibility from methicillin-sensitive S. aureus (MSSA) into CA-MRSA, it is highly recommended to screen MSSA for the presence of this gene [52].

Approximately 100% sensitivity to mupirocin was observed herein. This is in line with the other reports from Iran [8, 41]. Therefore, mupirocin can efficiently be used to mitigate MRSA nasal carriage [53]. Gentamicin is used as a synergic antibiotic in treatment of acute staphylococcal infections, like endocarditis. Fusidic acid is an appropriate alternative for the treatment of S. aureus infections in the cases of antibiotic resistance. In order to hinder the development of resistance against the above mentioned antimicrobials, diligent care in their use must be ensured. The same as the other internal data [8, 41], high rate of sensitivity against rifampin may be explained by the low prescription of this agent in medicine in Iran. Despite the reports from the northwest of Iran [8], high rate of resistance observed against clindamycin and erythromycin in this study may be a consequence of wide prescriptions of lincosamides and macrolides in treatment regime of gram positive bacterial infections in the region. Besides, there is obvious discrepancy regarding ciprofloxacin resistance rate in our study and others [8, 32, 41] which may be depend on the easy access of individuals to it without physicians prescriptions. Hence, prudent prescription and limited access of individuals to antimicrobial agents in the region is highly recommended.

Conclusion

In conclusion, the relatively high incidence of CA-MRSA in asymptomatic individuals in the west of Iran is a worrisome matter. Hence, implementation of follow-up programs is crucial to restrict and/or interrupt transmission of the bacteria from infected carriers to in-contact persons. Presence of either drug-resistance or pvl-harboring isolates may emphasize more the application of further continuous surveillance in the region.

Availability of data and materials

The datasets generated and/or analyzed during the current study are not publicly available since the data contains particular medical records and individual privacy could be compromised, but are available from the corresponding author on reasonable request.

Abbreviations

BA:

blood agar

CA:

Columbia agar

CA-MRSA:

community-acquired methicillin-resistant Staphylococcus aureus

CI:

confidence interval

HA-MRSA:

Hospital-acquired methicillin-resistant Staphylococcus aureus

MSA:

mannitol salt agar

OR:

odds ratio

PBP2a:

penicillin-binding protein

pvl :

Panton-Valentine Leukocidin

SANC:

Staphylococcus aureus nasal carriage

SCCmec :

staphylococcal cassette chromosome mec

SNS:

sterile normal saline

References

  1. 1.

    Pathak A, Marothi Y, Iyer RV, Singh B, Sharma M, Eriksson B, et al. Nasal carriage and antimicrobial susceptibility of Staphylococcus aureus in healthy preschool children in Ujjain. India BMC Pediatr. 2010;10:100.

    PubMed  Article  PubMed Central  Google Scholar 

  2. 2.

    Frank DN, Feazel LM, Bessesen MT, Price CS, Janoff EN, Pace NR. The human nasal microbiota and Staphylococcus aureus carriage. PLoS One. 2010;5(5):e10598.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  3. 3.

    von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group N Engl J Med. 2001;344(1):11–6.

    Article  Google Scholar 

  4. 4.

    Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7(9):629–41.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2000;44(6):1549–55.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Hao H, Dai M, Wang Y, Huang L, Yuan Z. Key genetic elements and regulation systems in methicillin-resistant Staphylococcus aureus. Future Microbiol. 2012;7(11):1315–29.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  8. 8.

    Abroo S, Hosseini Jazani N, Sharifi Y. Methicillin-resistant Staphylococcus aureus nasal carriage between healthy students of medical and nonmedical universities. Am J Infect Control. 2017;45(7):709–12.

    PubMed  Article  PubMed Central  Google Scholar 

  9. 9.

    Jackson KL, Mbagwu M, Pacheco JA, Baldridge AS, Viox DJ, Linneman JG, et al. Performance of an electronic health record-based phenotype algorithm to identify community associated methicillin-resistant Staphylococcus aureus cases and controls for genetic association studies. BMC Infect Dis. 2016;16(1):684.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  10. 10.

    Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-valentine leukocidin. Lab Investig. 2007;87(1):3–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  11. 11.

    Bartoloni A, Pallecchi L, Fernandez C, Mantella A, Riccobono E, Magnelli D, et al. Low prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in urban and rural community settings in Bolivia and Peru. Int J Infect Dis. 2013;17(5):e339–42.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  12. 12.

    Lozano C, Gomez-Sanz E, Benito D, Aspiroz C, Zarazaga M, Torres C. Staphylococcus aureus nasal carriage, virulence traits, antibiotic resistance mechanisms, and genetic lineages in healthy humans in Spain, with detection of CC398 and CC97 strains. Int J Med Microbiol. 2011;301(6):500–5.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  13. 13.

    Mehraj J, Akmatov MK, Strompl J, Gatzemeier A, Layer F, Werner G, et al. Methicillin-sensitive and methicillin-resistant Staphylococcus aureus nasal carriage in a random sample of non-hospitalized adult population in northern Germany. PLoS One. 2014;9(9):e107937.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  14. 14.

    Pires FV, da Cunha ML, Abraao LM, Martins PY, Camargo CH, Fortaleza CM. Nasal carriage of Staphylococcus aureus in Botucatu, Brazil: a population-based survey. PLoS One. 2014;9(3):e92537.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  15. 15.

    Mobasherizadeh S, Shojaei H, Havaei SA, Mostafavizadeh K, Davoodabadi F, Khorvash F, et al. Nasal carriage screening of community-associated methicillin resistant Staphylococcus aureus in healthy children of a developing country. Adv Biomed Res. 2016;5:144.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  16. 16.

    Nikfar R, Shamsizadeh A, Ziaei Kajbaf T, Kamali Panah M, Khaghani S, Moghddam M. Frequency of methicillin-resistant Staphylococcus aureus nasal carriage in healthy children. Iran J Microbiol. 2015;7(2):67–71.

    PubMed  PubMed Central  Google Scholar 

  17. 17.

    Rahimi F, Katouli M, Pourshafie MR. Characteristics of hospital- and community-acquired meticillin-resistant Staphylococcus aureus in Tehran. Iran J Med Microbiol. 2014;63:796–804.

    PubMed  Article  PubMed Central  Google Scholar 

  18. 18.

    Shokouhi S, Darazam IA, Zamanian MH. Community-acquired methicillin-resistant Staphylococcus aureus carriage rate and antimicrobial susceptibility in a tertiary center. Iran J Res Med Sci. 2017;22:71.

    PubMed  Article  PubMed Central  Google Scholar 

  19. 19.

    Brakstad OG, Aasbakk K, Maeland JA. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol. 1992;30(7):1654–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Wayne P. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing 2011.

  21. 21.

    Geha DJ, Uhl JR, Gustaferro CA, Persing DH. Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratory. J Clin Microbiol. 1994;32(7):1768–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Ghaznavi-Rad E, Nor Shamsudin M, Sekawi Z, van Belkum A, Neela V. A simplified multiplex PCR assay for fast and easy discrimination of globally distributed staphylococcal cassette chromosome mec types in meticillin-resistant Staphylococcus aureus. J Med Microbiol. 2010;59:1135–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  23. 23.

    Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvment of Panton-valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29(5):1128–32.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  24. 24.

    Liu SH, Chen KF, Chen CJ, Lin YH, Huang YC. Intermittent nasal carriage with Staphylococcusaureus within a menstrual cycle: results from a prospective cohort of healthy carriers. Medicine. 2016;95(26):e4040.

    PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Zanger P, Nurjadi D, Gaile M, Gabrysch S, Kremsner PG. Hormonal contraceptive use and persistent Staphylococcus aureus nasal carraige. Clin Infect Dis. 2012;55(12):1625–32.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  26. 26.

    Pennell LM, Galligan CL, Fish EN. Sex affects immunity. J Autoimmun. 2012;38(2–3):282–91.

    Article  CAS  Google Scholar 

  27. 27.

    Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007;28(5):521–74.

    CAS  Article  Google Scholar 

  28. 28.

    Siivonen L. Sex steroid receptors in papilloma, normal mucosa and polyps of the nose. ORL J Otorhinolaryngol Relat Spec. 1994;56(3):154–6.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  29. 29.

    Lamikanra A, Olusanya OI. A long-term study of the nasal carriage of Staphylococcus aureus in healthy Nigerian students. Trans R Soc Trop Med Hyg. 1988;82(3):500–2.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  30. 30.

    Skramm I, Moen AE, Bukholm G. Nasal carriage of Staphylococcus aureus: frequency and molecular diversity in a randomly sampled Norwegian community population. APMIS. 2011;119(8):522–8.

    PubMed  Article  PubMed Central  Google Scholar 

  31. 31.

    Fomda BA, Thokar MA, Khan A, Bhat JA, Zahoor D, Bashir G, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus among healthy population of Kashmir. India Indian J Med Microbiol. 2014;32(1):39–43.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  32. 32.

    Netsvyetayeva I, Fraczek M, Piskorska K, Golas M, Sikora M, Mlynarczyk A, et al. Staphylococcus aureus nasal carriage in Ukraine: antibacterial resistance and virulence factor encoding genes. BMC Infect Dis. 2014;14:128.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  33. 33.

    Durupt F, Mayor L, Bes M, Reverdy ME, Vandenesch F, Thomas L, et al. Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo. Br J Dermatol. 2007;157(6):1161–7.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  34. 34.

    Fritz SA, Epplin EK, Garbutt J, Storch GA. Skin infection in children colonized with community-associated methicillin-resistant Staphylococcus aureus. J Inf Secur. 2009;59(6):394–401.

    Google Scholar 

  35. 35.

    Ertam I, Biyikli SE, Yazkan FA, Aytimur D, Alper S. The frequency of nasal carriage in chronic urticaria patients. J Eur Acad Dermatol Venereol. 2007;21(6):777–80.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  36. 36.

    Talpur R, Bassett R, Duvic M. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome. Br J Dermatol. 2008;159(1):105–12.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  37. 37.

    Petry V, Lipnharski C, Bessa GR, Silveira VB, Weber MB, Bonamigo RR, et al. Prevalence of community-acquired methicillin-resistant Staphylococcus aureus and antibiotic resistance in patients with atopic dermatitis in Porto Alegre. Brazil Int J Dermatol. 2014;53(6):731–5.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  38. 38.

    Rahimian J, Khan R, LaScalea KA. Does nasal colonization or mupirocin treatment affect recurrence of methicillin-resistant Staphylococcus aureus skin and skin structure infections? Infect Control Hosp Epidemiol. 2007;28(12):1415–6.

    PubMed  Article  PubMed Central  Google Scholar 

  39. 39.

    Askarian M, Zeinalzadeh A, Japoni A, Alborzi A, Memish ZA. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi hospital, shiraz. Iran Int J Infect Dis. 2009;13(5):e241–7.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  40. 40.

    Mohajeri P, Izadi B, Rezaei M, Farahani A. Frequency distribution of hospital-acquired MRSA nasal carriage among hospitalized patients in west of Iran. Jundishapur J Microbiol. 2013;6(6):e9076.

    Google Scholar 

  41. 41.

    Japoni-Nejad A, Rezazadeh M, Kazemian H, Fardmousavi N, van Belkum A, Ghaznavi-Rad E. Molecular characterization of the first community-acquired methicillin-resistant Staphylococcus aureus strains from Central Iran. Int J Infect Dis. 2013;17(11):e949–54.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  42. 42.

    Goud R, Gupta S, Neogi U, Agarwal D, Naidu K. Community prevalence of methicillin and vancomycin resistant Staphylococcus aureus in and around Bangalore, southern India. Rev Soc Bras Med Trop. 2011;44(3):309–12.

    PubMed  Article  PubMed Central  Google Scholar 

  43. 43.

    Scerri J, Monecke S, Borg MA. Prevalence and characteristics of community carriage of methicillin-resistant Staphylococcus aureus in Malta. J Epidemiol Glob Health. 2013;3(3):165–73.

    PubMed  Article  PubMed Central  Google Scholar 

  44. 44.

    Onanuga A, Temedie TC. Nasal carriage of multi-drug resistant Staphylococcus aureus in healthy inhabitants of Amassoma in Niger delta region of Nigeria. Afr Health Sci. 2011;11(2):176–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. 45.

    Bratu S, Landman D, Gupta J, Trehan M, Panwar M, Quale J. A population-based study examining the emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York City. Ann Clin Microbiol Antimicrob. 2006;5:29.

    PubMed  PubMed Central  Article  Google Scholar 

  46. 46.

    Rihn JA, Paosfay-Barbe K, Harner CD, Macurak A, Farley A, Greenawalt K, et al. Community-acquired methicillin-resistant Staphylococcus aureus outbreak in a local high school football team unsuccessful interventions. Pediatr Infect Dis J. 2005;24(9):841–3.

    PubMed  Article  PubMed Central  Google Scholar 

  47. 47.

    Schaumburg F, Kock R, Friedrich AW, Soulanoudjingar S, Ngoa UA, von Eiff C, et al. Population structure of Staphylococcus aureus from remote African Babongo pygmies. PLoS Negl Trop Dis. 2011;5(5):e1150.

    PubMed  PubMed Central  Article  Google Scholar 

  48. 48.

    Fard-Mousavi N, Mosayebi G, Amouzandeh-Nobaveh A, Japouni-Nejad A, Ghaznavi-Rad E. The dynamic of Staphylococcus aureus nasal carriage in Central Iran. Jundishapur J Microbiol. 2015;8(7):e20760.

    PubMed  PubMed Central  Google Scholar 

  49. 49.

    Mainous AG 3rd, Hueston WJ, Everett CJ, Diaz VA. Nasal carriage of Staphylococcus aureus and methicillin-resistant S aureus in the United States, 2001-2002. Ann Fam Med. 2006;4(2):132–7.

    PubMed  PubMed Central  Article  Google Scholar 

  50. 50.

    David MZ, Glikman D, Crawford SA, Peng J, King KJ, Hostetler MA, et al. What is community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis. 2008;197(9):1235–43.

    PubMed  Article  PubMed Central  Google Scholar 

  51. 51.

    Zanger P, Nurjadi D, Schleucher R, Scherbaum H, Wolz C, Kremsner PG, et al. Import and spread of Panton-valentine Leukocidin-positive Staphylococcus aureus through nasal carriage and skin infections in travelers returning from the tropics and subtropics. Clin Infect Dis. 2012;54(4):483–92.

    PubMed  Article  PubMed Central  Google Scholar 

  52. 52.

    Deurenberg RH, Beisser PS, Visschert MJ, Driessen C, Stobberingh EE. Molecular typing of methicillin-susceptible Staphylococcus aureus isolates collected in the Yogyakarta area in Indonesia, 2006. Clin Microbiol Infect. 2010;16(1):92–4.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  53. 53.

    Henkel T, Finlay J. Emergence of resistance during mupirocin in treatment: is it a problem in clinical practice? J Chemother. 1999;11(5):331–7.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

Download references

Acknowledgments

Not Applicable.

Funding

None.

Author information

Affiliations

Authors

Contributions

This study was conceived by EA, MK, SMM, JB, and MR. The laboratory work was performed by FK-M and AK. EA wrote this article. All the authors have read and approved the manuscript.

Corresponding author

Correspondence to Elham Ahmadi.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Ethics Committee of the Sanandaj Medical University [no: 2340/01]. All subjects provided written informed consent. In the cases of participants less than 16 years old, consent was collected from the parents.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ahmadi, E., Khojasteh, M., Mortazavi, S. et al. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus nasal carriage in the West of Iran: a population-based cross-sectional study. BMC Infect Dis 19, 899 (2019). https://doi.org/10.1186/s12879-019-4567-1

Download citation

Keywords

  • CA-MRSA
  • SCCmec
  • Pvl
  • Antibiogram
  • Iran